AI assistant
INTELLIGENT BIO SOLUTIONS INC. — Director's Dealing 2020
Dec 30, 2020
35195_dirs_2020-12-30_2d46f3a4-97f1-4c1c-b771-a12c6718b790.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: GBS Inc. (GBS)
CIK: 0001725430
Period of Report: 2020-12-22
Reporting Person: Life Science Biosensor Diagnostics Pty Ltd (10% Owner)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 5747647 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Common Stock Purchase Warrant | $ | Common Stock (3000000) | Direct | ||
| Series A Warrants | $ | Common Stock (117647) | Direct | ||
| Series B Warrants | $ | Common Stock (117647) | Direct |
Footnotes
F1: Includes 5,630,000 held prior to the IPO and 117,647 acquired at the IPO.
F2: Includes a 5-year non-transferrable warrant to purchase 3,000,000 shares of the Company's common stock issuable at the exercise price of $17.00.
F3: Includes Series A warrant to purchase 117,647 shares of the Company's common stock at an exercise price equal to $8.50
per share exercisable until the fifth anniversary of the issuance date.
F4: Includes Series B warrant to purchase 117,647 shares of the Company's common stock and together with the Series A Warrants at an exercise price equal to $17.00 per share, exercisable until the fifth anniversary of the issuance date and subject to certain adjustment and cashless exercise provisions as described herein.